Hesperos, Inc
CAGE Code: 79R15
NCAGE Code: 79R15
Status: Active
Type: Commercial Supplier
Summary
Hesperos, Inc is an Active Commercial Supplier with the Cage Code 79R15.
Address
12501 Research Pkwy Ste 100
Orlando FL 32826-2908
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Veterans Edge Solutions, Llc Omnisource Events, Llc Certified Crane Services Inc Engine Power Supply Inc Affil Of Software Development Scandinavian Boiler Service, Inc. Lockheed Martin Corporation Encap Systems Corporation S H And E Inc Remedial Engineering And Science Inc Environmental Conservation Kent Electronics Asap Office Buildings Inc Striving Independence Home Care Llc Yesterdays Industries Inc United States Crane Certification Sunshine Coast Group Llc Global Technology Associates Inc. Laquita D. Clay Stellar Lighting Systems Llc
Frequently Asked Questions (FAQ) for CAGE 79R15
- What is CAGE Code 79R15?
- 79R15 is the unique identifier used by NATO Organizations to reference the physical entity known as Hesperos, Inc located at 12501 Research Pkwy Ste 100, Orlando FL 32826-2908, United States.
- Who is CAGE Code 79R15?
- 79R15 refers to Hesperos, Inc located at 12501 Research Pkwy Ste 100, Orlando FL 32826-2908, United States.
- Where is CAGE Code 79R15 Located?
- CAGE Code 79R15 is located in Orlando, FL, USA.
Contracting History for CAGE 79R15 Most Recent 25 Records
- 75N95021P00296
- Eo14042 - Ncats Project Phase Ii Supplement - Target Validation And Therapeutic Evaluation In Ngly1deficient Chip-Based Models
- 28 Oct 2021
- Eo14042 - Ncats Project Phase Ii Supplement - Target Validation And Therapeutic Evaluation In Ngly1deficient Chip-Based Models
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $142,843.00
- Department Of Health And Human Services (Hhs)
- 75N95021P00296
- Ncats Project Phase Ii Supplement - Target Validation And Therapeutic Evaluation In Ngly1deficient Chip-Based Models
- 29 Dec 2022
- Ncats Project Phase Ii Supplement - Target Validation And Therapeutic Evaluation In Ngly1deficient Chip-Based Models
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $142,843.00
- Department Of Health And Human Services (Hhs)
- 75N95021P00296
- Ncats Project Phase Ii Supplement - Target Validation And Therapeutic Evaluation In Ngly1deficient Chip-Based Models, Pop: 6/21/2021-10/20/2021
- 21 Jun 2021
- Ncats Project Phase Ii Supplement - Target Validation And Therapeutic Evaluation In Ngly1deficient Chip-Based Models, Pop: 6/21/2021-10/20/2021
- National Institutes Of Health Nida
- Department Of Health And Human Services (Hhs)
- $142,843.00
- Department Of Health And Human Services (Hhs)